Vivimed Labs Limited

NSEI:VIVIMEDLAB Stock Report

Market Cap: ₹410.4m

Vivimed Labs Dividends and Buybacks

Dividend criteria checks 0/6

Vivimed Labs does not currently pay a dividend.

Key information

0%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio0%

Recent dividend and buyback updates

No updates

Recent updates

Is Vivimed Labs (NSE:VIVIMEDLAB) Weighed On By Its Debt Load?

Mar 30
Is Vivimed Labs (NSE:VIVIMEDLAB) Weighed On By Its Debt Load?

Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?

Dec 14
Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?

Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)

Jun 30
Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)

Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)

Feb 22
Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)

Did Vivimed Labs Limited (NSE:VIVIMEDLAB) Insiders Buy Up More Shares?

Jan 19
Did Vivimed Labs Limited (NSE:VIVIMEDLAB) Insiders Buy Up More Shares?

Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?

Nov 25
Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?

Are Insiders Buying Vivimed Labs Limited (NSE:VIVIMEDLAB) Stock?

Sep 22
Are Insiders Buying Vivimed Labs Limited (NSE:VIVIMEDLAB) Stock?

Is Vivimed Labs (NSE:VIVIMEDLAB) Using Debt In A Risky Way?

Jul 31
Is Vivimed Labs (NSE:VIVIMEDLAB) Using Debt In A Risky Way?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if VIVIMEDLAB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VIVIMEDLAB's dividend payments have been increasing.


Dividend Yield vs Market

Vivimed Labs Dividend Yield vs Market
How does VIVIMEDLAB dividend yield compare to the market?
SegmentDividend Yield
Company (VIVIMEDLAB)0%
Market Bottom 25% (IN)0.2%
Market Top 25% (IN)1.1%
Industry Average (Pharmaceuticals)0.7%
Analyst forecast (VIVIMEDLAB) (up to 3 years)n/a

Notable Dividend: Unable to evaluate VIVIMEDLAB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VIVIMEDLAB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: VIVIMEDLAB is not paying a notable dividend for the Indian market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as VIVIMEDLAB has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/28 15:42
End of Day Share Price 2023/07/31 00:00
Earnings2023/06/30
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vivimed Labs Limited is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rashmi Sancheti ShettyAnand Rathi Shares and Stock Brokers Limited
Anil BurraFirstCall Research
null nullK.R. Choksey Shares & Securities Private Ltd.